BioCentury | Sep 11, 2019
Financial News
With $22M B round, OncoCell to launch prostate cancer test
...its diagnostic platform based on immune gene expression profiles. Mark McDonough, president and CEO of OncoCell Mdx Inc....
...antigens (see “Adaptive is Surfing a Wave of Enthusiasm in Disease Detection” ). Sandi Wong, Staff Writer OncoCell MDx Inc. Prostate...
...antigens (see “Adaptive is Surfing a Wave of Enthusiasm in Disease Detection” ). Sandi Wong, Staff Writer OncoCell MDx Inc. Prostate...
